[HTML][HTML] Lys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro.
JC Fredenburgh, ME Nesheim - Journal of Biological Chemistry, 1992 - Elsevier
JC Fredenburgh, ME Nesheim
Journal of Biological Chemistry, 1992•ElsevierPlasminogen, the zymogen form of the fibrinolytic enzyme plasmin, is known to undergo
plasmin-mediated modification in vitro. The modified form, Lys-plasminogen, is superior to
the native Glu-plasminogen in fibrin binding and as a substrate for activation by tissue-type
plasminogen activator (t-PA). The present study was undertaken to determine the existence
and significance of the Glu-to Lys-plasminogen conversion during t-PA-mediated lysis of
plasma clots in vitro. When human plasma was supplemented with exogenous Lys …
plasmin-mediated modification in vitro. The modified form, Lys-plasminogen, is superior to
the native Glu-plasminogen in fibrin binding and as a substrate for activation by tissue-type
plasminogen activator (t-PA). The present study was undertaken to determine the existence
and significance of the Glu-to Lys-plasminogen conversion during t-PA-mediated lysis of
plasma clots in vitro. When human plasma was supplemented with exogenous Lys …
Plasminogen, the zymogen form of the fibrinolytic enzyme plasmin, is known to undergo plasmin-mediated modification in vitro. The modified form, Lys-plasminogen, is superior to the native Glu-plasminogen in fibrin binding and as a substrate for activation by tissue-type plasminogen activator (t-PA). The present study was undertaken to determine the existence and significance of the Glu- to Lys-plasminogen conversion during t-PA-mediated lysis of plasma clots in vitro. When human plasma was supplemented with exogenous Lys-plasminogen and clotted, a dose-dependent shortening of lysis time was observed. Formation of Lys-plasminogen in situ during fibrinolysis was determined using 131I-Glu-plasminogen-supplemented plasma. By the time of lysis, Lys-plasminogen had accumulated to about 20% of the initial concentration of Glu-plasminogen. Quantitation of activation of both Glu- and Lys-plasminogen as well as the conversion of Glu- to Lys-plasminogen in plasma supplemented with both 131I-Glu-plasminogen and 125I-Lys-plasminogen was accomplished by determining the flux of the isotopically labeled species along three pathways: Glu-plasminogen–>Glu-plasmin, Glu-plasminogen–>Lys-plasminogen, and Lys-plasminogen–>Lys-plasmin. After a brief lag, the Glu-plasminogen activation rate was constant until lysis was achieved, at which point activation ceased. The Lys-plasminogen activation rate also was essentially constant until lysis but was not characterized by a lag phase. The rate of conversion of Glu- to Lys-plasminogen was nonlinear and correlated directly with the rate of fibrinolysis. By the time lysis had occurred, Glu-plasminogen consumption had been distributed equally between direct activation to plasmin and conversion to Lys-plasminogen, and 45% of the plasmin which had been formed was derived from Lys-plasminogen. These results demonstrate both the formation and the subsequent activation of Lys-plasminogen during fibrinolysis. As a result of improved fibrin binding and activation of Lys-plasminogen compared to Glu-plasminogen, the formation of Lys-plasminogen within a clot constitutes a positive feedback mechanism that can further stimulate the activation of plasminogen by t-PA as fibrinolysis progresses.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果